Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Current Deferred Revenue (2016 - 2018)

Updated

Kazia Therapeutics' Current Deferred Revenue was $97,217 in fiscal Q4 2018 (quarter ended Dec 31, 2018), up 204.2% from $31,957 a year earlier.

Analysis

Kazia Therapeutics (KZIA) Current Deferred Revenue (2016 - 2018) Analysis & Trends

  • In earlier fiscal years, Current Deferred Revenue was $31,957 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Kazia Therapeutics 10.72 Mn -41.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 97,217.33
Jun 30, 2018 101,381.13
Dec 31, 2017 31,956.60
Jun 30, 2017 31,509.38
Dec 31, 2016 132,989.43
Jun 30, 2016 30,628.97
API Access

Kazia Therapeutics Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=KZIA&period=max&api_key=YOUR_API_KEY